Search Results

Firms vie to treat genetic disease.

Subjects: THERAPEUTIC use of enzymes; PATENTS; TRANSKARYOTIC Therapies Inc.

• Source: Science News; 11/04/2000, Vol. 158 Issue 19, p303, 1/4p

Record details

Genzyme and TKT collaborate to develop and commercialize I2S for Hunter syndrome.

Subjects: BUSINESS partnerships; ENZYMES; SULFATASESGENZYME Corp.; TRANSKARYOTIC Therapies Inc.

• Source: PharmaWatch: Biotechnology; November 2003, Vol. 2 Issue 11, p22-22, 1p

Record details

New in the Marketplace.

Subjects: DRUGS; PHARMACEUTICAL industryTRANSKARYOTIC Therapies Inc.; GENZYME Corp.; IMCLONE Systems Inc.

• Source: Drugs & Therapy Perspectives; Apr2004, Vol. 20 Issue 4, p26-26, 1/2p, 1 Chart

Record details

Fabry Disease Rivals Shake Hands.

• Authors : Jarvis, Lisa

Subjects: *DEALS; *BIOTECHNOLOGY industriesTRANSKARYOTIC Therapies Inc. 196355366 TRANSKARYOTIC Therapies Inc. TRANSKARYOTIC Therapies Inc. 196355366 196355366 TRANSKARYOTIC Therapies Inc. 196355366 TKTX; GENZYME Corp. 025322157 GENZYME Corp. GENZYME Corp. 025322157 025322157 GENZYME Corp. 025322157 GENZ

• Source: Chemical Market Reporter. 10/20/2003, Vol. 264 Issue 13, p8. 1/3p.

Record details

Genzyme Leads Fabry Race.

Subjects: *DRUGSUNITED StatesGENZYME Corp. 025322157 GENZYME Corp. GENZYME Corp. 025322157 025322157 GENZYME Corp. 025322157 GENZ; TRANSKARYOTIC Therapies Inc. 196355366 TRANSKARYOTIC Therapies Inc. TRANSKARYOTIC Therapies Inc. 196355366 196355366 TRANSKARYOTIC Therapies Inc. 196355366 TKTX; UNITED States. Food & Drug Administration

• Source: Chemical Market Reporter. 1/20/2003, Vol. 263 Issue 3, p9. 1/6p.

Record details

TKT Prevails in Genzyme Suit.

• Authors : Krause, Carey

Subjects: *DRUGS; *PATENT infringementGENZYME Corp. 025322157 GENZYME Corp. GENZYME Corp. 025322157 025322157 GENZYME Corp. 025322157 GENZ; TRANSKARYOTIC Therapies Inc. 196355366 TRANSKARYOTIC Therapies Inc. TRANSKARYOTIC Therapies Inc. 196355366 196355366 TRANSKARYOTIC Therapies Inc. 196355366 TKTX

• Source: Chemical Market Reporter. 12/24/2001, Vol. 260 Issue 24, p7. 3/8p.

Record details

TKT Suited to Win Fabry Disease Ruling Against Genzyme.

Subjects: *PATENT infringementTRANSKARYOTIC Therapies Inc. 196355366 TRANSKARYOTIC Therapies Inc. TRANSKARYOTIC Therapies Inc. 196355366 196355366 TRANSKARYOTIC Therapies Inc. 196355366 TKTX; GENZYME Corp. 025322157 GENZYME Corp. GENZYME Corp. 025322157 025322157 GENZYME Corp. 025322157 GENZ

• Source: Chemical Market Reporter. 12/10/2001, Vol. 260 Issue 22, p11. 1/5p.

Record details

Genzyme's Fabry Disease Drug on Track.

Subjects: *DRUG marketing; *RULES; *GOVERNMENT policyUNITED StatesUNITED States. Food & Drug Administration ; TRANSKARYOTIC Therapies Inc. 196355366 TRANSKARYOTIC Therapies Inc. TRANSKARYOTIC Therapies Inc. 196355366 196355366 TRANSKARYOTIC Therapies Inc. 196355366 TKTX; GENZYME Corp. 025322157 GENZYME Corp. GENZYME Corp. 025322157 025322157 GENZYME Corp. 025322157 GENZ

• Source: Chemical Market Reporter. 10/29/2001, Vol. 260 Issue 16, p11. 1/9p.

Record details

Genzyme, Transkaryotic Square Off In Niche Market for Fabry's Disease.

• Authors : Krause, Carey

Subjects: *DRUGSEUROPEGENZYME Corp. 025322157 GENZYME Corp. GENZYME Corp. 025322157 025322157 GENZYME Corp. 025322157 GENZ; TRANSKARYOTIC Therapies Inc. 196355366 TRANSKARYOTIC Therapies Inc. TRANSKARYOTIC Therapies Inc. 196355366 196355366 TRANSKARYOTIC Therapies Inc. 196355366 TKTX

• Source: Chemical Market Reporter. 8/13/2001, Vol. 260 Issue 7, p10. 1/4p.

Record details

Genzyme Files Patent Infringement Suit Against Transkaryotic.

• Authors : Pollack, Andrew

Subjects: TRANSKARYOTIC Therapies Inc.; PATENT infringement; GENZYME Corp.

• Source: New York Times. 07/26/2000, Vol. 149 Issue 51461, pC6. 0p.

Record details